Literature DB >> 25241933

Prognostic evaluation of severe sepsis and septic shock: procalcitonin clearance vs Δ Sequential Organ Failure Assessment.

José R A de Azevedo1, Orlando J M Torres2, Rafael A Beraldi3, Carmen A P M Ribas4, Osvaldo Malafaia3.   

Abstract

PURPOSE: The purpose of the study is to compare the clearance of procalcitonin (PCT-c) in the first 24 and 48 hours of treatment of severe sepsis and septic shock with another early prognostic marker represented by the 48-hour Δ Sequential Organ Failure Assessment (SOFA).
MATERIALS AND METHODS: Prospective, observational cohort study conducted in a general intensive care unit including patients with severe sepsis and septic shock. The PCT-c was determined at the diagnosis of sepsis and after 24 and 48 hours. The SOFA score was determined at the time of intensive care unit admission and after 48 hours.
RESULTS: One hundred thirty adult patients with severe sepsis and septic shock were studied over an 18-month period. The 24- and 48-hour PTC-c scores were significantly higher in survivors (P < .0001). In nonsurvivors, the initial SOFA was significantly higher, and the 48-hour Δ SOFA was significantly smaller (P = .01). The area under the receiver operating characteristic curve was 0.68 for Δ SOFA and 0.76 for 24- and 48-hour PCT-c.
CONCLUSIONS: The 48-hour Δ SOFA score and the clearance of 24- and 48-hour PCT are useful markers of prognosis in patients with severe sepsis and septic shock. A decrease in PCT-c in the first 24 hours of treatment should prompt the reassessment of the appropriateness and adequacy of treatment.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biomarker; Procalcitonin; Prognosis; SOFA score; Septic shock; Severe sepsis

Mesh:

Substances:

Year:  2014        PMID: 25241933     DOI: 10.1016/j.jcrc.2014.08.018

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  16 in total

Review 1.  Immune therapy in sepsis: Are we ready to try again?

Authors:  Roger Davies; Kieran O'Dea; Anthony Gordon
Journal:  J Intensive Care Soc       Date:  2018-04-04

Review 2.  Laboratory Diagnosis of Sepsis? No SIRS, Not Just Yet.

Authors:  W Michael Dunne
Journal:  J Clin Microbiol       Date:  2015-01-28       Impact factor: 5.948

Review 3.  Diagnosing and Managing Sepsis by Probing the Host Response to Infection: Advances, Opportunities, and Challenges.

Authors:  Ian L Gunsolus; Timothy E Sweeney; Oliver Liesenfeld; Nathan A Ledeboer
Journal:  J Clin Microbiol       Date:  2019-06-25       Impact factor: 5.948

Review 4.  Procalcitonin: Where Are We Now?

Authors:  Bachar Hamade; David T Huang
Journal:  Crit Care Clin       Date:  2019-10-21       Impact factor: 3.598

5.  Dynamic changes in heparin-binding protein as a prognostic biomarker for 30-day mortality in sepsis patients in the intensive care unit.

Authors:  Qing-Li Dou; Jiangping Liu; Wenwu Zhang; Ching-Wei Wang; Yanan Gu; Na Li; Rui Hu; Wan-Ting Hsu; Amy Huaishiuan Huang; Hoi Sin Tong; Tzu-Chun Hsu; Cheng-An Hsu; Jun Xu; Chien-Chang Lee
Journal:  Sci Rep       Date:  2022-06-24       Impact factor: 4.996

Review 6.  Prognostic value of procalcitonin in hospitalized patients with lower respiratory tract infections.

Authors:  Vandack Nobre; Isabela Borges
Journal:  Rev Bras Ter Intensiva       Date:  2016-06

7.  Early Kinetics of Procalcitonin in Predicting Surgical Outcomes in Type A Aortic Dissection Patients.

Authors:  Hua Liu; Zhe Luo; Lan Liu; Xiao-Mei Yang; Ya-Min Zhuang; Ying Zhang; Guo-Wei Tu; Guo-Guang Ma; Guang-Wei Hao; Jian-Feng Luo; Ji-Li Zheng; Chun-Sheng Wang
Journal:  Chin Med J (Engl)       Date:  2017-05-20       Impact factor: 2.628

8.  Diagnostic Accuracy of Procalcitonin for Differentiating Bacteraemic Gram-Negative Sepsis from Gram-Positive Sepsis.

Authors:  Beliz Bilgili; Murat Haliloğlu; Melek Süzer Aslan; İsmet Sayan; Umut Sabri Kasapoğlu; İsmail Cinel
Journal:  Turk J Anaesthesiol Reanim       Date:  2018-02-01

Review 9.  Biomarkers for Sepsis: What Is and What Might Be?

Authors:  Bethany M Biron; Alfred Ayala; Joanne L Lomas-Neira
Journal:  Biomark Insights       Date:  2015-09-15

10.  Assessment of Diagnostic and Prognostic Role of Copeptin in the Clinical Setting of Sepsis.

Authors:  Stefania Battista; Umberto Audisio; Claudia Galluzzo; Matteo Maggiorotto; Monica Masoero; Daniela Forno; Elisa Pizzolato; Marco Ulla; Manuela Lucchiari; Annarita Vitale; Corrado Moiraghi; Enrico Lupia; Fabio Settanni; Giulio Mengozzi
Journal:  Biomed Res Int       Date:  2016-06-06       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.